adenosine monophosphate has been researched along with Myasthenia Gravis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| DuBrock, HM; Peters, BJ; Rabinstein, AA | 1 |
| Bhagavan, SM; Govindarajan, R; Ramaswamy, SB | 1 |
2 other study(ies) available for adenosine monophosphate and Myasthenia Gravis
| Article | Year |
|---|---|
Use of Remdesivir in Myasthenia gravis and COVID-19.
Topics: Adenosine Monophosphate; Adult; Aged; Alanine; Anti-Inflammatory Agents; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Dexamethasone; Fatal Outcome; Female; Humans; Male; Middle Aged; Myasthenia Gravis; Treatment Outcome | 2021 |
A case report of COVID-19 in refractory myasthenia: Outcome with remdesivir and dexamethasone.
Topics: Adenosine Monophosphate; Aged; Alanine; Antiviral Agents; COVID-19 Drug Treatment; Dexamethasone; Drug Therapy, Combination; Glucocorticoids; Humans; Male; Myasthenia Gravis; Plasmapheresis; Pneumonia, Viral; SARS-CoV-2 | 2021 |